Tandem Diabetes Care, Inc.Pembelian
Smart money created and bought the dip
Recent analyst downgrade was no less than pure manipulation to create new long term holders, most likely institutional holders as we are approaching the Sep 25th conference. Most analysts are still bullish, and there are several catalysts ahead through 2020 like t:sport, Control-IQ, sales on Basal-IQ, international expansion, and possible UHC coverage. Tandem also seems to have a great management team.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.